Merck just splashed out up to US $576 m to buy preclinical Calporta. To get access to its neurological drugs.
Thats $850M. So tell me again why NEU is only worth $400-$500m?
https://www.fiercebiotech.com/biotech/merck-buys-calporta-for-preclinical-neurodegeneration-assets
Bell Potter lifts target to A$4.40/Share Vs A$3.75, page-55
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.87 |
Change
0.260(1.91%) |
Mkt cap ! $1.784B | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.00 | $13.51 | $2.642M | 191.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 217 | $13.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.87 | 457 | 11 |
View Market Depth
| Last trade - 14.55pm 13/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |